TABLE 2.
Unadjusted iron bioavailability, status, and inflammatory markers at weeks 0 and 4 of each supplementation period1
| Supplementation period, g | ||||||
|---|---|---|---|---|---|---|
| 0.03 | 0.25 | 1.5 | ||||
| Parameter | Week 0 | Week 4 | Week 0 | Week 4 | Week 0 | Week 4 |
| Maximum iron absorption, % | 12.7 (7.5, 17.9) | 10.7 (5.4, 15.9) | 12.1 (6.9, 17.3) | 12.4 (7.2, 17.6) | 11.2 (6.0, 16.5) | 10.3 (5.0, 15.5) |
| iAUC for serum iron, µg/dL ⋅ h | 2155 (612, 3696) | 2269 (727, 3810) | 2461 (919, 4003) | 2769 (1228, 4311) | 2237 (696, 3779) | 2277 (735, 3819) |
| Hemoglobin, g/dL | 13.2 (13.0, 13.4) | 13.3 (13.1, 13.5) | 13.3 (13.1, 13.5) | 13.4 (13.2, 13.6) | 13.4 (13.1, 13.5) | 13.3 (13.2, 13.6) |
| Ferritin, ng/mL | 35.4 (28.4, 42.4) | 42.3 (35.3, 49.3) | 35.8 (28.8, 42.8) | 37.3 (30.3, 44.3) | 40.0 (33.0, 47.0) | 44.5 (37.5, 51.5) |
| CRP, mg/dL | 0.2 (0.0, 0.5) | 0.3 (0.0, 0.5) | 0.3 (0.1, 0.5) | 0.2 (0.0, 0.4) | 0.2 (0, 0.4) | 0.3 (0.1, 0.6) |
1
Values are means (95% CIs). No significant differences were noted (P > 0.05). CRP, C-reactive protein; iAUC, incremental AUC.